Show simple item record

dc.contributor.authorEskin, Fatih
dc.contributor.authorAkyol, Sumeyya
dc.contributor.authorAkyol, Omer
dc.contributor.authorSahin, Abdullah Fahri
dc.contributor.authorBEDİR, ABDULKERİM
dc.contributor.authorErdemli, Haci Kemal
dc.contributor.authorKocabas, Ramazan
dc.contributor.authorŞALIŞ, OSMAN
dc.contributor.authorSen, Fatma
dc.date.accessioned2021-03-06T09:44:12Z
dc.date.available2021-03-06T09:44:12Z
dc.date.issued2016
dc.identifier.citationErdemli H. K. , Kocabas R., ŞALIŞ O., Sen F., Akyol S., Eskin F., Akyol O., BEDİR A., Sahin A. F. , "Is Serum Caveolin-1 a Useful Biomarker for Progression in Patients with Colorectal Cancer?", CLINICAL LABORATORY, cilt.62, ss.401-408, 2016
dc.identifier.issn1433-6510
dc.identifier.othervv_1032021
dc.identifier.otherav_e6e74996-b3e2-4b8a-8dca-37b0769b4821
dc.identifier.urihttp://hdl.handle.net/20.500.12627/151886
dc.identifier.urihttps://doi.org/10.7754/clin.lab.2015.150719
dc.description.abstractBackground: Colorectal cancer (CRC) is the third most common cause of cancer diagnosed in males and the second in females. Survival is strongly related to stage at diagnosis. There is an urgent need to find a noninvasive biomarker that can be commonly applied for screening diagnosis, early detection of recurrence, and monitoring of metastatic CRC. Protein caveolin-1 (CAV-1) has been known to be expressed abnormally in colon cancer and appears to contribute to aberrant signaling and protein trafficking. There are controversial results regarding the role of CAV-1 in cancer. We hypothesized that levels of CAV-1 in serum of patients with CRC might be important to estimate the progression of the disease. Therefore, the purpose of this study is to investigate whether serum CAV-1 might be used as a factor determining progression of CRC.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.titleIs Serum Caveolin-1 a Useful Biomarker for Progression in Patients with Colorectal Cancer?
dc.typeMakale
dc.relation.journalCLINICAL LABORATORY
dc.contributor.departmentCorum Training & Research Hospital , ,
dc.identifier.volume62
dc.identifier.issue3
dc.identifier.startpage401
dc.identifier.endpage408
dc.contributor.firstauthorID229152


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record